IRIS NEOVASCULARISATION

This adverse event was reported 125 times

These drugs are most commonly taken by patients reporting IRIS NEOVASCULARISATION:

# Drug Count
0 BEVACIZUMAB 16
1 MELPHALAN HYDROCHLORIDE 15
2 RANIBIZUMAB 15
3 CARBOPLATIN 12
4 PEGCETACOPLAN 10
5 DEXAMETHASONE 9
6 AFLIBERCEPT 7
7 LATANOPROST 6
8 METFORMIN 6
9 METFORMIN ER 500 MG 6
See all common drugs associated with IRIS NEOVASCULARISATION

IRIS NEOVASCULARISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OMIDENEPAG ISOPROPYL 1 0.0152
1 METEX 2 0.0053
2 PEGCETACOPLAN 10 0.0053
3 TETRACAINE 1 0.0025
4 BRIMONIDINE TARTRATE AND TIMOLOL MALEATE 1 0.0025
5 HYALURONIC ACID 1 0.0009
6 ACETAZOLAMIDE SODIUM 5 0.0008
7 FLUOCINOLONE ACETONIDE 3 0.0008
8 VERTEPORFIN FOR INJECTION 1 0.0007
9 HYALURONATE SODIUM 1 0.0007
See all drugs enriched for association with IRIS NEOVASCULARISATION